Latest Revenue Guidance News

oOh!media reports a 7% revenue increase in Q3 2025, slightly ahead of prior guidance, but flags challenges from a key New Zealand contract loss and softer advertising demand in October.

Nova Eye Medical reported a 20% year-on-year revenue increase in Q1 FY26, reaffirming its FY26 sales guidance and targeting breakeven EBITDA by June 2026 amid cautious commercial expansion.

Austin Engineering has lowered its FY26 revenue and EBIT forecasts due to challenges in key contracts and operational inefficiencies, while outlining strategic measures to restore profitability.

Bioxyne Limited, through its subsidiary Breathe Life Sciences, has inked an exclusive deal to import, manufacture, and distribute Curaleaf’s Que Medical Inhalation Device in Australia, with a nationwide launch set for November 2025.

Electro Optic Systems (EOS) reports a surge in contract backlog to $415 million, anchored by a landmark $125 million export order for a high-energy laser weapon. Despite a $34.3 million operating cash outflow in Q3, EOS is poised for growth with new defence contracts and product innovations.

Enlitic, Inc. reported a strong quarter with record cash receipts and contract wins, yet withdrew its revenue guidance due to delayed project completions. The company remains confident in reaching operational cash flow break-even by the end of Q4 FY25.

Bioxyne Limited has reported a record-breaking first quarter for FY26, with revenues soaring 210% year-on-year, driven by strong demand in cannabis products and strategic European market advances.

Ava Risk Group reported a solid start to FY2026 with $9 million in Q1 sales orders and a $7.5 million backlog, underpinning its guidance for a profitable first half.

Fluence Corporation reported a robust 72.9% revenue increase in Q3 2025, driven by a strategic pivot towards higher-margin Smart Product Solutions and recurring revenue streams. The company maintains its full-year guidance despite expecting to finish near the lower end.

TZ Limited reports steady sales growth and new Microsoft contracts in Q1 FY2026, reaffirming its $17–21 million revenue guidance amid improving market conditions.

Cann Group Limited has executed a transformative debt restructure, reducing its $70 million debt by 81% and raising $9 million in fresh capital, setting the stage for a positive EBITDA turnaround in FY26.

Qoria Limited reported a strong start to FY2026, with annual recurring revenue climbing 25% year-on-year and record cash receipts of $46.3 million, prompting an upgrade to its full-year revenue guidance.